Huang J, Tong Y, Hong J, Huang O, et al. Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial. Breast Cancer Res Treat 2022 Dec 16. doi: 10.1007/s10549-022-06821.
PMID: 36525180